Abstract New Zealand obese (NZO/HlLt) male mice develop polygenic diabetes and altered phosphatidylcholine metabolism. The gene encoding phosphatidylcholine transfer protein (PC-TP) is sited within the support interval for Nidd3, a recessive NZO-derived locus on Chromosome 11 identified by prior segregation analysis between NZO/HlLt and NON/Lt. Sequence analysis revealed that the NZO-derived PC-TP contained a non-synonymous point mutation that resulted in an Arg120His substitution, which was shared by the related NZB/BlNJ and NZW/LacJ mouse strains. Consistent with the structure-based predictions, functional studies demonstrated that Arg120His PC-TP was inactive, suggesting that this mutation contributes to the deficiencies in phosphatidylcholine metabolism observed in NZO mice.
Introduction
The New Zealand obese (NZO) mouse strain is characterized by juvenile-onset obesity and maturity-onset hyperinsulinemia, hyperleptinemia, hyperglycemia, and hypertension. Approximately 50% of NZO males develop obesity-associated diabetes, or diabesity. Nonobese nondiabetic (NON) is an unrelated mouse strain that spontaneously develops impaired glucose tolerance associated with defective insulin secretion by pancreatic beta cells. In contrast to NZO, male NON mice do not progress from impaired glucose tolerance to hyperglycemia when maintained on standard diets. When NON and NZO are intercrossed, quantitative trait loci (QTL) derived from both strains produce (NZOxNON)F1 male mice of equivalent obesity to NZO parentals, but the frequency of males developing diabesity is increased to 90-100% [1, 2] .
In a effort to identify the genetic differences that underlie the tendency of NZO mice to develop diabesity, we recently showed that hepatic activities of two key enzymes of phosphatidylcholine (PC) metabolism, phosphatidylethanolamine nmethyl transferase (PEMT) and choline kinase were lower in (NZOxNON)F1 males than in either parental strain [3, 4] . The Pemt gene encoding PEMT is sited on Chromosome 11 within the support interval for the more proximal of two linkage peaks designated as Nidd3, an NZO-derived QTL controlling serum insulin concentrations [1] . We tested the hypothesis that an additional NZO-derived gene contributing to the unexpected reduction in PC metabolism in the metabolic milieu of the F1 mice might reside in the support interval for the more distal linkage peak comprising Nidd3. Indeed, this region was found to contain Pctp, the gene encoding phosphatidylcholine transfer protein (PC-TP). PC-TP is a highly specific 25 kDa PC binding protein that is enriched in cytosol of hepatocytes [5, 6] and regulates lipid metabolism in the liver [7] [8] [9] . In the present report, we show that the NZO genome carries a functionally null Pctp allele, which was present only in two other closely related New Zealand mouse strains.
Materials and methods

Materials
Restriction endonucleases, as well as all other routine molecular reagents were purchased from either Roche Applied Science (Indianapolis, IN) or Invitrogen (Carlsbad, CA). Egg yolk PC, brain phosphatidylserine (PS) and bovine heart cardiolipin were from Avanti Polar Lipids (Alabaster, AL). L L-a-1-Palmitoyl-2-linoleoyl-[linoleoyl- [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C] PC (50 mCi/mmol) was from NEN Life Science Products (Boston, MA) and [1a,a(n)- 3 H] and cholesteryl oleate (44 Ci/mmol) was from Amersham Biosciences (GE Healthcare Bio-Sciences Corp., Piscataway, NJ).
Mice
Mice were maintained on a chow diet containing 6% fat at The Jackson Laboratory (Bar Harbor, ME) in temperature and humidity controlled rooms with 14/10-h light-dark cycles. At 8 weeks of age, mice were euthanized by CO 2 asphyxiation. Livers were harvested immediately and then snap frozen and stored at À80°C. Genomic DNA samples from individual mouse strains listed in Table 1 were obtained from the DNA Resource of The Jackson Laboratory. All protocols were approved by the institutions' Animal Care and Use Committees.
Abbreviations: MLV, multilamellar vesicle; NON, nonobese nondiabetic; NZO, New Zealand obese; PC, phosphatidylcholine; PC-TP, PC transfer protein; PEMT, phosphatidylethanolamine n-methyl transferase; PS, phosphatidylserine; QTL, quantitative trait locus; SUV, small unilamellar vesicle
Quantitative real-time PCR
Hepatic mRNA expression of PC-TP was determined by quantitative real-time PCR. Total liver RNA was isolated for preparation of cDNA by standard techniques. Pctp-specific PCR primer sequences were 5 0 -ATAACCATCTACCGGCTGCT-3 0 (forward) and 5 0 -CAAGGTTGCTTGGGAATGAG-3 0 (reverse). Quantitative realtime PCR was performed on a LightCycler (Roche Applied Science) using SYBR green for DNA detection and cyclophilin RNA for normalization.
Western blot analysis PC-TP
Protein expression in liver homogenates was determined by Western blot analysis using three different polyclonal antibodies: (1) to the Cterminus of PC-TP (aa 200-214) [10] , (2) to an internal peptide (aa 50-63) [11] and (3) to purified recombinant wild type PC-TP [11] . Blots were stripped and reprobed with a MAP/ERK kinase 1 antibody (catalog number PRB-260C, Covance, Richmond, CA) to control for differences in protein loading. Detection was by enhanced chemiluminescence.
Nucleotide sequence analysis and predicted protein structures
The exons and 5 0 -flanking region of Pctp were amplified using PCR primers designed to the nucleotide sequence of the C57BL/6J strain (http://www.ensembl.org/Mus_musculus) and then subjected to nucleotide sequencing in both forward and reverse directions. Multiple nucleotide and amino acid sequence alignments were performed using CLUSTALW and visualized with Jalview [12, 13] . The crystal structure of PC-TP in complex with di-linoleoyl-phosphatidylcholine (Protein Data Bank entry 1LN1) was modeled as the Arg120His mutant using O [14] , which was also used to measure interatomic distances. The side chain dihedral angles near side chain rotamer values (v 1 = 176°) were modeled by inspection and produced no unacceptably close contacts to the remainder of the protein or ligand.
In vitro activity of wild type and mutated PC-TPs
A QuickChange Site-Directed Mutagenesis kit (Stratagene Cloning Systems, La Jolla, CA) was used to modify a synthetic human PC-TP cDNA that was cloned into pET11a (Novagen, EMD Biosciences, San Diego, CA) [11] so that it instead encoded Arg120His PC-TP. Mutagenesis was confirmed by nucleotide sequencing. Wild type and Arg120His in pET11a, as well as pET11a vector alone were transformed into E. coli BL21(DE3). Activities of native and recombinant expressed proteins were determined in cytosolic preparations from mouse livers and E. coli, respectively. Briefly, PC transfer activity was determined by measurement of intermembrane transfer of radiolabeled phospholipids [15] . Donor small unilamellar vesicles (SUVs) were prepared by bath sonication of PC, 14 C-PC, 3 H-cholesteryl oleate dispersed in 5 mM EDTA and 50 mM Tris at pH 7. H ratio of SUVs. Specific activities were estimated by normalizing activities to cytosolic expression levels, which were quantified by densitometric analysis of Western blots [16] .
Membrane binding of wild type and mutated -PC-TPs
Binding of wild type and Arg120His PC-TP to SUVs was measured as previously described [11] . To produce wild type and mutated PCTPs in the form of His-tag fusion proteins, we cloned cDNAs encoding wild type and Arg120His into pET19b (Novagen). His-tag proteins were purified from soluble bacterial proteins [11] and dialyzed against 10 mM Tris-HCl, 20 mM NaCl, 1 mM DTT and 1 mM NaN 3 at 4°C. Proteins were mixed together with SUVs (PC:PS molar ratio of 80:20) to a final volume 200 ll. The final protein concentration (1.5 lM) was held constant, whereas the SUV phospholipid concentration was varied to achieve phospholipid/protein molar ratios of 0-240. Mixtures were incubated for 10 min at room temperature to allow binding of proteins to SUV, and then unbound proteins were collected by ultrafiltration through Microcon YM100 100 kDa molecular weight cutoff filter (Millipore, Bedford, MA) by centrifugation at 3000 · g for 5 min. Unbound proteins remaining within the filter were eluted by centrifugation (3000 · g for 2 min) of an addition 300 ll of buffer and were combined with initial ultrafiltrates. Ultrafiltrates containing unbound proteins were transferred to PVDF membranes (Immobilon-P, Millipore) using a Bio-Dot SF Cell slot-blot apparatus (BioRad Laboratories, Hercules, CA) and probed with the antibody raised to the C-terminus of PC-TP. Detection was by enhanced chemiluminescence.
Results
Fig. 1 presents a schematic diagram of the previously-reported NZO-derived QTL for Nidd3 on Chromosome 11 [1] that drew our attention to the possibility that the NZO Pctp allele, because of its chromosomal position, might contribute to the impaired PC metabolism. Indeed, as shown in Fig. 2 , multiple nucleotide sequence polymorphisms distinguished the NZO Pctp allele from the other strains chosen for comparative sequencing (NON/Lt, NOD/Lt, and C57BL/6J). Within the gene promoter region 86 bp upstream from the transcription initiation site, an A-to-G substitution within the CAATbox of the putative promoter [17] distinguishes NZO from the other 3 unrelated strains sequenced. Between the CAAT box and transcription initiation site in NZO mice, we also observed that the 12 bp spanning between bp À80 to À69 were deleted from the promoter region of Pctp. Two polymorphisms were observed within the NZO coding region of Pctp. A syn- 0 -UTR, a series of 7 G bases beginning at bp 935 downstream of the transcription initiation site in C57BL/6J mice was replaced with 9 G bases in NZO and 11 G bases in NON. Beginning at bp 1492, the 15 bp sequence in C57BL/ 6J was replaced by 17 G bases in NZO mice and 14 G bases in NON mice. To gain additional insights into the temporal origins of this substitution among mouse strains, we amplified and sequenced exon 4 of Pctp from a variety of mouse strains including the two closely-related NZB and NZW strains ( Table 1 ). The Arg120His substitution was present only in the Pctp alleles of the NZO-related NZB and NZW strains, but not in a variety of other strains.
The finding of NZO polymorphisms in the gene promoter and 3
0 -UTR of Pctp suggested the possibility that mRNA expression levels might be altered. However, quantitative real-time PCR revealed that mRNA levels of Pctp in livers of NZO mice were the same as in the NON and the F1 hybrid (NZOXNON)F1 mouse strains. By Western blot analysis using each of three different anti-PC-TP antibodies, PC-TP protein concentrations did not differ in livers of NZO and NON mice (data not shown). Expression levels were also the same in (NZOxNON)F1 mice. Fig. 3 illustrates the environment surrounding residue 120 in the three dimensional structure of PC-TP [18] . The crystal structure of PC-TP in its native form [16] reveals that Arg120 interacts directly with the side chains of Asp70 and Asp122. Asp70 is a member of helix a2 (residues 64-74), which donates two additional residues to the PC binding site: Leu68, which interacts with the sn-2 acyl chain of the bound PC molecule, and Tyr72, which also interacts with the sn-2 chain and additionally interacts with the phosphoryl group of PC via its side chain hydroxyl. Although mutation of Arg to His at position 120 conserves the positive charge, the His side chain is shorter than the native Arg residue and would not be expected to interact with Asp70 in the same manner although it could interact with Asp122 (imidazole NE2 atom to Asp 122 side chain OD1 atom distance of 2.50 Å ). This altered interaction of residue 120 with a2 would be predicted to affect the conformation or position of this helix and mediate altered interactions of Leu68 and Tyr72 with the ligand, and perhaps alter the activity of the protein as a result. Based upon this structure-based prediction, we evaluated the influence of the Arg120His mutation on the activity of native and recombinant PC-TP. We did not detect a difference in the PC transfer There was an A-G substitution at bp À86 within in the CCAAT-box of the promoter region and a deletion (represented by dashes) of 12 bp from À80 to À69. A C-to-T substitution at bp 338 within exon 3 was synonymous, leaving Ser at aa 110 unaltered. However, a G-to-A substitution at bp 367 in exon 4, was non-synonymous, resulting the substitution of Arg at aa 120 with His. There were two additional sequence differences outside the coding region in exon 6, each of which consisted of two bp insertions in NZO mice, as well as a 4 bp insertion and a 1 bp deletion in the NON strain. activity of cytosolic proteins (up to 200 lg added in the in vitro assay) from livers of NZO and NON mice. However, as shown in Fig. 4A , robust PC transfer activity was observed for recombinant wild type protein, which increased in this assay in proportion to the amount that was added, whereas minimal activity was observed for the recombinant Arg120His mutant protein, which did not differ from the vector control.
Because genetic outcross between NZO and NON produces an F1 male that is comparably obese, but develops diabesity at a higher frequency than observed in NZO parental males [19] , we questioned whether the increased diabesity penetrance might entail a further impairment of PC homeostasis via a dominant-negative inactivation of the NON wild type (Arg120) protein by the mutant NZO His120 PC-TP protein.
Using the in vitro assay, we admixed wild type and mutant recombinant PC-TPs in varied molar ratios (Fig. 4B) . We observed an essentially linear increase in the activity of the wild type PC-TP as its molar percentage in the mixture increased, arguing against a dominant-negative effect of the mutant protein. Fig. 4C compares membrane binding of wild type and Arg120His PC-TPs, as measured by the concentration of free protein that passed through a filter that retained SUVs. As the phospholipids/protein ratio was increased, reduced band intensity was indicative of PC-TP binding to SUVs. These data demonstrate that the Arg120His mutation did not reduce the capacity of PC-TP bind to membranes.
Discussion
The present study shows that the NZO/HlLtJ strain and its two most closely related strains, NZB/BlNJ and NZW/LacJ all share the same inactivating Arg120His mutation in their Pctp allele. PC-TP is a member of the steroidogenic acute regulatory (StAR)-related transfer (START) domain-containing superfamily of proteins [20, 21] and has also been designated StarD2 [22] . The gene encoding PC-TP is highly conserved among mammals [6, 17, 23, 24] . It is expressed in a number of human [24] and mouse [23] tissues, but highest levels are generally found in the liver. Experiments in tissue culture [25, 26] and in mice with homozygous disruption of Pctp [7] [8] [9] suggest a role for PC-TP in hepatobiliary elimination of plasma cholesterol.
Although we observed nucleotide sequence polymorphisms in both the promoter region and the 3 0 UTR of the NZO Pctp gene, these did not influence hepatic mRNA expression levels. Similarly there were no differences in PC-TP protein in livers of NZO or NON mice, indicating that the Arg120His substitution did not alter protein stability. However, a notable observation in this study was that the Arg120His amino acid substitution inactivated recombinant expressed PC-TP in an assay of intermembrane PC exchange. Although we did not observe a difference in PC transfer activity between cytosolic protein preparations from livers of NZO and NON mice, this result most likely reflects the relative insensitivity of the in vitro assay when PC-TP comprises a small fraction of the total protein in the assay, taken together with the contributions of other soluble proteins in liver that exhibit PC transfer activity (e.g. sterol carrier protein 2, StarD10 and phosphatidylinositol transfer protein) [27] . It is also possible that another lipid transfer protein may have compensated for the loss of PC-TP activity in livers of NZO mice.
PC-TP binds PC non-covalently in a tight 1:1 stoichiometric complex [5, 16] . Its activity as a lipid transfer protein has been well characterized using carefully standardized in vitro assays [5] . To accomplish PC exchange, PC-TP must bind to a donor membrane, release a PC molecule within its lipid-binding pocket and then bind to a new one. Structural studies of PC-TP [11, 16] indicate that PC exchange at the membrane requires a major conformational change in the protein. Once exchange occurs, PC-TP must then desorb from the donor and bind to an acceptor membrane, where a similar exchange of PC occurs. A failure of any of these steps could have disrupted the activity of recombinant PC-TP that was measured in the in vitro transfer activity used in this study [28] . Arg in position 120 of PC-TP is conserved among humans, cows, rats and mice [6] , supporting the likelihood that its conversion to His might lead to significant alterations in protein structure and function. Based upon the predicted structure of Arg120His PC-TP, it appears likely that the inability to transfer PC between membranes results from altered binding of PC within the lipid-binding pocket of the protein. This possibility is supported by the observation that the Arg120His substitution did not influence membrane binding by PC-TP, which is mediated at least in part by the C-terminal a-helix of the protein [11] . Although the physiological significance of inactivating PC-TP is not known, these results are suggestive that the spontaneous mutation of PC-TP adds to the additional defects in PC biosynthesis elicited by reduced activities of PEMT and choline kinase in the liver of NZO males [3] .
The finding that only NZO, NZB, and NZW mice share the Arg120His mutation indicates that the mutation had become fixed in the outbred progenitors maintained at the University of Otago, New Zealand, prior to initiation of NZ inbred strain development in 1948. The NZO and NZB strain had common agouti progenitors and were separated at the third generation of sib mating, at which point the latter strain was selected for black coat color while selection for agouti coat and later, obesity, was continued in the NZO line [29] . Although deriving from the same outbred stock, the NZW strain was independently selected for albino coat color from different progenitors than used to form the NZO and NZB lines [30] .
In summary, nucleotide sequence analysis of Pctp revealed differences between the NZO and NON alleles in both noncoding and coding regions. One of the polymorphisms in the coding region of the NZO allele resulted in an Arg120His substitution, a change that abrogated the in vitro activity of PC-TP without inhibiting membrane binding. The finding of the same Arg120His substitution in NZB and NZW Pctp shows this mutation is not of recent origin. Admixture experiments in vitro with cytosolic proteins from transformed E. coli producing wild type or mutant PC-TP failed to show a dominant negative effect of the null allele product on wild-type activity. Although the physiological significance of inactivating PC-TP is not known, the demonstration of a functionally null Pctp allele in the NZO genome, coupled with reduced activities of the PC biosynthetic PEMT and choline kinase enzymes [3] in the liver of NZO males, further indicates significant derangements in lipid metabolism in this mouse model of polygenic obesity and diabesity.
